Aromatase and COX in breast cancer: enzyme inhibitors and beyond
about
In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.Steroid hormone transforming aldo-keto reductases and cancer.Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen.Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer.Selective regulation of aromatase expression for drug discovery.Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women.Analgesic use and patterns of estrogen metabolism in premenopausal women.Genetics of androgen metabolism in women with infertility and hypoandrogenism.SPANosomes as delivery vehicles for small interfering RNA (siRNA).Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR4 and of uPA system.Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.Effects of Pomegranate Juice on Hormonal Biomarkers of Breast Cancer Risk.Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.
P2860
Q33468636-32C694A2-2F81-45B1-8E0D-1F3E1209BF9EQ33503908-5E0E9823-189C-4B12-B02A-5F88C325FBB9Q34571239-D6952D15-6C51-4016-8A2E-4B0E09D3551CQ35796937-9FED15E4-E20F-41D2-A1B5-E36EA2C2F1EEQ35870384-2F168BEB-EC38-44FB-B667-6B65D2711DA7Q36802719-751DCF13-52C9-452C-93EF-0FDF6B6AFCADQ36916609-C99AF975-5E5D-426D-B03E-EB0277BEF1DDQ37686568-1CB16C1F-2416-4E27-AEED-AD2BD8BE1520Q38460006-351331F8-0A0C-4121-BD7F-7035CDB71AC9Q39431804-AB37C7B0-BD67-4E44-BA4C-42CA099DB493Q39531178-18BAD827-ADBB-4824-A849-1F3CE4771AE4Q39622594-386E7812-953A-45EB-ADDD-3E4E80763F2EQ41434593-C07E5E2D-0D83-4B1D-9F2C-D9C5AA78A61CQ51382532-E14B0AA5-3976-477B-8C45-101CA56CD282
P2860
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@ast
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@en
type
label
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@ast
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@en
prefLabel
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@ast
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@en
P2093
P2860
P1476
Aromatase and COX in breast cancer: enzyme inhibitors and beyond
@en
P2093
Danyetta D Davis
Edgar S Díaz-Cruz
Robert W Brueggemeier
P2860
P356
10.1016/J.JSBMB.2007.05.021
P50
P577
2007-05-25T00:00:00Z